Kevin Tang
Tang Capital Management Llc
Assets Managed
$1.969B
Holdings
51
Last Quarter
2026 - Q1
Filed Date
11d ago
Growth Rate
-2.73%(2Q avg: -12.4%)
Sustained Growth
0 quarters
Portfolio positions
This chart displays the top 10 holdings in Tang Capital Management Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 51 positions.
Assets under management
The assets under management (AUM) of Tang Capital Management Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 1.969B in assets, with a quarterly growth rate of -2.73% and a 2-quarter average growth rate of -12.4%. The portfolio is managed by Kevin Tang, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
AUPH Aurinia Pharmaceuticals Inc
| 9.21% | $181.241M 12.23M shares@ $14.82 avg price | Increased 7.95% |
CELC Celcuity Inc
| 6.09% | $119.847M 1.05M shares@ $114.14 avg price | |
MIRM Mirum Pharmaceuticals Inc
| 5.8% | $114.184M 1.236M shares@ $92.38 avg price | |
GLPG Galapagos Nv-spon Adr
| 5.77% | $113.58M 3.786M shares@ $30.0 avg price | Decreased -3.44% |
SPY Spdr S&p 500 Etf Trust
| 5.55% | $109.257M 168,000 shares@ $650.34 avg price | Increased 460% |
KNSA Kiniksa Pharmaceuticals Inte
| 5.53% | $108.814M 2.26M shares@ $48.15 avg price | |
CAPR Capricor Therapeutics Inc
| 5.25% | $103.357M 3.4M shares@ $30.4 avg price | Increased 100% |
PTCT Ptc Therapeutics Inc
| 5.2% | $102.195M 1.5M shares@ $68.13 avg price | |
SYRE Spyre Therapeutics Inc
| 4.85% | $95.443M 1.892M shares@ $50.44 avg price | |
KALV Kalvista Pharmaceuticals Inc
| 4.68% | $92.065M 4.574M shares@ $20.14 avg price |
1-10 of 51